Stifel raised the firm’s price target on Crane (CR) to $200 from $189 and keeps a Hold rating on the shares following “a beat and raise” quarter. The company is winning key programs and technology to position the A&E segment for continued growth over the coming years, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CR:
- Crane Company Reports Strong Q2 2025 Results
- Crane Company Earnings Call Highlights Strong Growth and Strategic Moves
- Closing Bell Movers: Sarepta surges as FDA may lift Elevidys shipments pause
- Crane reports Q2 adjusted EPS $1.49, consensus $1.33
- Crane raises FY25 EPS view to $5.50-$5.80 from $5.30-$5.60